We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




Medtronic Acquires Medina Medical

By HospiMedica International staff writers
Posted on 14 Sep 2015
Print article
Image: The Medina Embolization Device (Photo courtesy of Medina Medical).
Image: The Medina Embolization Device (Photo courtesy of Medina Medical).
Medtronic (Dublin, Ireland) has acquired Medina Medical (Menlo Park, CA, USA), a privately-held company that has developed a novel embolization framing coil for treating brain aneurysms.

Medtronic had previously invested in Medina Medical and held an ownership stake in the company prior to completion of the all-cash acquisition, which includes an initial payment of USD 150 million, with additional payments conditional upon achievement of key milestones. Additional financial terms were not disclosed. The Medina Medical product line will join the company’s neurovascular division within the restorative therapies group.

“Medtronic is committed to fighting stroke through the innovative therapies we bring to clinicians and patients. Medina Medical's breakthrough technology makes it a natural fit with our Neurovascular portfolio, further strengthening our hemorrhagic stroke portfolio,” said Brett Wall, president of the neurovascular division at Medtronic. “The Medina embolization device features advanced technology to treat cerebral aneurysms that we think can one day disrupt the coil market.”

“This acquisition offers Medina Medical a unique opportunity to bring together our breakthrough technologies with Medtronic's leading clinical, regulatory, market development, and commercial expertise,” said Erik Engelson, CEO of Medina Medical. “We look forward to working closely with Medtronic to provide expanded access and economic efficiencies to our clinical partners in fighting stroke—particularly aneurysms and hemorrhagic stroke.”

The Medina Embolization Device is an intrasaccular 3-D mesh implant that is packed into a brain aneurysm. The technology addresses clinical needs by unfolding a 3-D self-expandable mesh to provide a scaffold across the aneurysm neck that conforms to the shape of the aneurysm and reduces blood flow. The embolization device has received the European Community CE marking, but has not yet been approved by the [US] Food and Drug Administration (FDA) for commercial distribution.

Related Links:

Medtronic
Medina Medical


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
New
Mobile Power Procedure Chair
LeMans P360
New
Anterior Cervical Plate System
XTEND

Print article

Channels

Surgical Techniques

view channel
Image: The surgical team and the Edge Multi-Port Endoscopic Surgical Robot MP1000 surgical system (Photo courtesy of Wei Zhang)

Endoscopic Surgical System Enables Remote Robot-Assisted Laparoscopic Hysterectomy

Telemedicine enables patients in remote areas to access consultations and treatments, overcoming challenges related to the uneven distribution and availability of medical resources. However, the execution... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.